高级光动力学治疗中的聚合物微粒:设计,交付和转化前景
Alžběta Turnovská1, Tomáš Etrych1
1Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, Prague 6, 162 00, Czechia.
International journal of pharmaceutics: X
|December 1, 2025
概括
聚合物微粒为癌症治疗的光动力学疗法 (PDT) 提供光敏剂 (PSs) 的有前途解决方案. 这些纳米载体增强了PS的溶解性,稳定性和向性传递,克服了PDT的关键局限性.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 光动力疗法 (PDT) 是一种微创的癌症治疗方法,使用光敏剂 (PSs),光和氧.
- 有效的PDT结果取决于常规PSS的受控输送.
- 聚合物微粒被探索为一种药物输送系统,以克服PS的溶解性和稳定性挑战.
研究的目的:
- 审查聚合物微粒的应用和局限性,以控制抗癌治疗中的光敏剂输送.
- 详细说明微粒系统的合成,PS结合,释放和激活方法.
- 评估细胞系统对PS药理动力学和瘤向的影响.
主要方法:
- 关于聚合物微粒合成和表征的文献综述.
- 分析将光敏感剂纳入小粒体的方法.
- 在体外和体内研究的讨论,关于小胞PS输送和光动力学效应.
主要成果:
- 聚合物微粒提高了光敏剂的溶解性,稳定性和循环时间.
- 细胞系统提供了被动和主动向的潜力,减少了非目标效应.
- 从细胞中控制释放和激活PSs可以提高治疗效果.
结论:
- 聚合物微粒代表了一种多功能平台,用于优化光动力学治疗中的光敏剂输送.
- 需要对先进的细胞设计和红移/双光子吸收系统进行进一步的研究,以克服PDT的局限性,例如浅层组织透.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


